Next-generation sequencing in Charcot–Marie–Tooth disease: opportunities and challenges

Barreto, C. L. S. et al. Epidemiologic study of Charcot-Marie-Tooth disease: a systematic review. Neuroepidemiology 46, 157–165 (2016). 10.1159/000443706

[3]

Reilly, M. M., Murphy, S. M. & Laura, M. Charcot-Marie-Tooth disease. J. Peripher. Nerv. Syst. 16, 1–14 (2011). 10.1111/j.1529-8027.2011.00324.x

[4]

Feely, S. M. E. et al. MFN2 mutations cause severe phenotypes in most patients with CMT2A. Neurology 76, 1690–1696 (2011). 10.1212/wnl.0b013e31821a441e

[5]

Harding, A. E. & Thomas, P. K. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 103, 259–280 (1980). 10.1093/brain/103.2.259

[6]

Mathis, S. et al. Charcot-Marie-Tooth diseases: an update and some new proposals for the classification. J. Med. Genet. 52, 681–690 (2015). 10.1136/jmedgenet-2015-103272

[7]

Rossor, A. M. et al. Peripheral neuropathy in complex inherited diseases: an approach to diagnosis. J. Neurol. Neurosurg. Psychiatry 88, 846–863 (2017). 10.1136/jnnp-2016-313960

[8]

Fridman, V. et al. CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium Natural History study: a cross-sectional analysis. J. Neurol. Neurosurg. Psychiatry 86, 873–878 (2015). 10.1136/jnnp-2014-308826

[9]

Rossor, A. M., Tomaselli, P. J. & Reilly, M. M. Recent advances in the genetic neuropathies. Curr. Opin. Neurol. 29, 537–548 (2016). 10.1097/wco.0000000000000373

[10]

Murphy, S. M. et al. Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing. J. Neurol. Neurosurg. Psychiatry 83, 706–710 (2012). 10.1136/jnnp-2012-302451

[11]

Saporta, A. S. D. et al. Charcot-Marie-Tooth disease subtypes and genetic testing strategies. Ann. Neurol. 69, 22–33 (2011). 10.1002/ana.22166

[12]

Rossor, A. M., Polke, J. M., Houlden, H. & Reilly, M. M. Clinical implications of genetic advances in Charcot-Marie-Tooth disease. Nat. Rev. Neurol. 9, 562–571 (2013). 10.1038/nrneurol.2013.179

[13]

ClinVar: improving access to variant interpretations and supporting evidence

Melissa J Landrum, Jennifer M Lee, Mark Benson et al.

Nucleic Acids Research 2018 10.1093/nar/gkx1153

[14]

Analysis of protein-coding genetic variation in 60,706 humans

Monkol Lek, Konrad J. Karczewski, Eric V. Minikel et al.

Nature 2016 10.1038/nature19057

[15]

Zuk, O. et al. Searching for missing heritability: designing rare variant association studies. Proc. Natl Acad. Sci. USA 111, E455–E464 (2014). 10.1073/pnas.1322563111

[16]

Marttila, M. et al. Molecular epidemiology of Charcot-Marie-Tooth disease in Northern Ostrobothnia, Finland: a population-based study. Neuroepidemiology 49, 34–39 (2017). 10.1159/000478860

[17]

Gabrikova, D. et al. Founder mutations in NDRG1 and HK1 genes are common causes of inherited neuropathies among Roma/Gypsies in Slovakia. J. Appl. Genet. 54, 455–460 (2013). 10.1007/s13353-013-0168-7

[18]

Lupo, V. et al. Characterising the phenotype and mode of inheritance of patients with inherited peripheral neuropathies carrying MME mutations. J. Med. Genet. 55, 814–823 (2018). 10.1136/jmedgenet-2018-105650

[19]

Higuchi, Y. et al. Mutations in MME cause an autosomal-recessive Charcot-Marie-Tooth disease type 2. Ann. Neurol. 79, 659–672 (2016). 10.1002/ana.24612

[20]

Gilissen, C. et al. Genome sequencing identifies major causes of severe intellectual disability. Nature 511, 344–347 (2014). 10.1038/nature13394

[21]

Antoniadi, T. et al. Application of targeted multi-gene panel testing for the diagnosis of inherited peripheral neuropathy provides a high diagnostic yield with unexpected phenotype-genotype variability. BMC Med. Genet. 16, 84 (2015). 10.1186/s12881-015-0224-8

[22]

Nam, S. H. et al. Identification of genetic causes of inherited peripheral neuropathies by targeted gene panel sequencing. Mol. Cells 39, 382–388 (2016). 10.14348/molcells.2016.2288

[23]

Lupo, V. et al. Assessment of targeted next-generation sequencing as a tool for the diagnosis of Charcot-Marie-Tooth disease and hereditary motor neuropathy. J. Mol. Diagn. 18, 225–234 (2016). 10.1016/j.jmoldx.2015.10.005

[24]

Yoshimura, A. et al. Genetic profile and onset features of 1005 patients with Charcot-Marie-Tooth disease in Japan. J. Neurol. Neurosurg. Psychiatry 90, 195–202 (2018). 10.1136/jnnp-2018-318839

[25]

Wang, W. et al. Target-enrichment sequencing and copy number evaluation in inherited polyneuropathy. Neurology 86, 1762–1771 (2016). 10.1212/wnl.0000000000002659

[26]

Meienberg, J., Bruggmann, R., Oexle, K. & Matyas, G. Clinical sequencing: is WGS the better WES? Hum. Genet. 135, 359–362 (2016). 10.1007/s00439-015-1631-9

[27]

Choi, B. O. et al. Exome sequencing is an efficient tool for genetic screening of Charcot-Marie-Tooth disease. Hum. Mutat. 33, 1610–1615 (2012). 10.1002/humu.22143

[28]

Drew, A. P. et al. Improved inherited peripheral neuropathy genetic diagnosis by whole-exome sequencing. Mol. Genet. Genomic Med. 3, 143–154 (2015). 10.1002/mgg3.126

[29]

Gonzaga-Jauregui, C. et al. Exome sequence analysis suggests that genetic burden contributes to phenotypic variability and complex neuropathy. Cell Rep. 12, 1169–1183 (2015). 10.1016/j.celrep.2015.07.023

[30]

Hartley, T. et al. Whole-exome sequencing is a valuable diagnostic tool for inherited peripheral neuropathies: outcomes from a cohort of 50 families. Clin. Genet. 93, 301–309 (2018). 10.1111/cge.13101

[31]

Yang, Y. et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N. Engl. J. Med. 369, 1502–1511 (2013). 10.1056/nejmoa1306555

[32]

Bansagi, B. et al. Genetic heterogeneity of motor neuropathies. Neurology 88, 1226–1234 (2017). 10.1212/wnl.0000000000003772

[33]

Jo, H. Y. et al. Application of whole-exome sequencing for detecting copy number variants in CMT1A/HNPP. Clin. Genet. 90, 177–181 (2016). 10.1111/cge.12714

[34]

Belkadi, A. et al. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants. Proc. Natl Acad. Sci. USA 112, 5473–5478 (2015). 10.1073/pnas.1418631112

[35]

Lelieveld, S. H., Spielmann, M., Mundlos, S., Veltman, J. A. & Gilissen, C. Comparison of exome and genome sequencing technologies for the complete capture of protein-coding regions. Hum. Mutat. 36, 815–822 (2015). 10.1002/humu.22813

[36]

Dewey, F. E. et al. Clinical interpretation and implications of whole-genome sequencing. JAMA 311, 1035–1045 (2014). 10.1001/jama.2014.1717

[37]

Carss, K. J. et al. Comprehensive rare variant analysis via whole-genome sequencing to determine the molecular pathology of inherited retinal disease. Am. J. Hum. Genet. 100, 75–90 (2017). 10.1016/j.ajhg.2016.12.003

[38]

Wright, C. F., FitzPatrick, D. R. & Firth, H. V. Paediatric genomics: diagnosing rare disease in children. Nat. Rev. Genet. 19, 253–268 (2018). 10.1038/nrg.2017.116

[39]

Taylor, J. C. et al. Factors influencing success of clinical genome sequencing across a broad spectrum of disorders. Nat. Genet. 47, 717–726 (2015). 10.1038/ng.3304

[40]

Lupski, J. R. et al. Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N. Engl. J. Med. 362, 1181–1191 (2010). 10.1056/nejmoa0908094

[41]

Brewer, M. H. et al. Whole genome sequencing identifies a 78kb insertion from chromosome 8 as the cause of Charcot-Marie-Tooth neuropathy CMTX3. PLOS Genet. 12, e1006177 (2016). 10.1371/journal.pgen.1006177

[42]

Drew, A. P., Cutrupi, A. N., Brewer, M. H., Nicholson, G. A. & Kennerson, M. L. A 1.35Mb DNA fragment is inserted into the DHMN1 locus on chromosome 7q34–q36.2. Hum. Genet. 135, 1269–1278 (2016). 10.1007/s00439-016-1720-4

[43]

Raymond, F. L., Horvath, R. & Chinnery, P. F. First-line genomic diagnosis of mitochondrial disorders. Nat. Rev. Genet. 19, 399–400 (2018). 10.1038/s41576-018-0022-1

[44]

Minoche, A. E. et al. Genome sequencing as a first-line genetic test in familial dilated cardiomyopathy. Genet. Med. 21, 650–662 (2018). 10.1038/s41436-018-0084-7

[45]

Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data

Caroline F Wright, Tomas W Fitzgerald, Wendy D Jones et al.

The Lancet 2015 10.1016/s0140-6736(14)61705-0

[46]

Turnbull, C. et al. The 100 000 Genomes Project: bringing whole genome sequencing to the NHS. BMJ 361, k1687 (2018). 10.1136/bmj.k1687

[47]

Gonzalez, M. et al. Innovative genomic collaboration using the GENESIS (GEM.app) platform. Hum. Mutat. 36, 950–956 (2015). 10.1002/humu.22836

[48]

Nadeau, J. H. Modifier genes in mice and humans. Nat. Rev. Genet. 2, 165–174 (2001). 10.1038/35056009

[49]

Barnett, I. J., Lee, S. & Lin, X. Detecting rare variant effects using extreme phenotype sampling in sequencing association studies. Genet. Epidemiol. 37, 142–151 (2013). 10.1002/gepi.21699

[50]

Tao, F. et al. Variation in SIPA1L2 is correlated with phenotype modification in Charcot-Marie-Tooth disease type 1A. Ann. Neurol. 85, 316–330 (2019). 10.1002/ana.25426

Showing 50 of 101 references

Cited By

177

Advances and challenges in modeling Charcot-Marie-Tooth type 2A using iPSC-derived models

Mafalda Rizzuti, Elisa Pagliari · 2025

Stem Cell Reports

Current profile of Charcot‐Marie‐Tooth disease in Africa: A systematic review

Abdoulaye Yalcouyé, Kevin Esoh · 2022

Journal of the Peripheral Nervous S...

Mitochondrial Fission and Fusion: Molecular Mechanisms, Biological Functions, and Related Disorders

Mode Al Ojaimi, Azza Salah · 2022

Membranes

Treating PMP22 gene duplication-related Charcot-Marie-Tooth disease: the past, the present and the future

Suzan Boutary, Andoni Echaniz-Laguna · 2021

Translational Research

Metrics

177

Citations

101

References

Details

Published: Oct 03, 2019
Vol/Issue: 15(11)
Pages: 644-656
License: View

Authors

M

Menelaos Pipis

Department of Neuromuscular Diseases, University College London, London, UK; National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK

Cite This Article

Menelaos Pipis, Alexander M. Rossor, Matilde Laura, et al. (2019). Next-generation sequencing in Charcot–Marie–Tooth disease: opportunities and challenges. Nature Reviews Neurology, 15(11), 644-656. https://doi.org/10.1038/s41582-019-0254-5

Next-generation sequencing in Charcot–Marie–Tooth disease: opportunities and challenges

You May Also Like